THORSON JON S has a total of 16 patent applications. Its first patent ever was published in 2004. It filed its patents most often in United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets biotechnology, organic fine chemistry and pharmaceuticals are YAMASA CORP, HEBEI SHENGXUE DACHENG PHARMACEUTICAL CO LTD and NANTONG QIUZHIYOU BIOSCIENCE & BIOTECHNOLOGY CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 13 | |
#2 | WIPO (World Intellectual Property Organization) | 3 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Organic fine chemistry | |
#3 | Pharmaceuticals | |
#4 | Measurement | |
#5 | Machines |
# | Technology | |
---|---|---|
#1 | Sugars | |
#2 | Microorganisms | |
#3 | Fermentation | |
#4 | Therapeutic chemical compounds | |
#5 | Analysing materials | |
#6 | Peptides | |
#7 | Unspecified technologies | |
#8 | Combinatorial chemistry | |
#9 | Measuring microorganism processes | |
#10 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Thorson Jon S | 16 |
#2 | Griffith Byron R | 3 |
#3 | Fitzgibbon John R | 2 |
#4 | Gantt Richard W | 2 |
#5 | Timmons Shannon C | 2 |
#6 | Aqeel Ahmed | 1 |
#7 | Williams Gavin J | 1 |
#8 | Zhang Changsgeng | 1 |
#9 | Goff Randal D | 1 |
Publication | Filing date | Title |
---|---|---|
US2012094946A1 | Glycosylated chlorambucil analogs and uses thereof | |
US2011306074A1 | Glycosyltransferase reversibility for sugar nucleotide synthesis | |
WO2010014814A2 | Glycosylated warfarin analogs and uses thereof | |
US2009317829A1 | High-throughput assay for sugar-mediated drug transport | |
US2009181854A1 | Engineered glycosyltransferases with expanded substrate specificity | |
WO2008140887A1 | Nucleotidyltransferases with enhanced nucleotide triphosphate flexibility |